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Abstract-The time course of N.N-dimethyltryptamine (DMT) levels in brain and liver of adult male 
Holtzman rats was determined with and without pretreatment with the monoamine oxidase inhibitors 
iproniazid (32 mg/kg) and tranylcypromine (IO mg/kg) given i.p. DMT was given in doses of 1.0. 3.2 
and 10.0 mg/kg i.p. DMT was assayed spectrophotofluorometrically and in some Instances by a radio- 
isotopic method. The results show that the half-life of DMT varied with different doses m the brain 
but not in the liver. Pretreatment with the monoamine oxidase inhibitors prolonged the total period 
during which DMT was found. A linear relationship exists between the mean time required to reach 
minimal DMT concentrations and the mean duration of suppression of FR, barpressing behavior 
in rats trained for a milk reward. The results suggest a direct involvement of DMT in inducing behav- 
ioral toxicity. 
N,N-dimethyltryptamine (DMT) is one of the hallu- 
cinogenic indolealkylamines [l-3]. Biosynthetic path- 
ways exist for the potential synthesis of DMT irk ciz:o 
[4-S]. This hallucinogen has been implicated in the 
pathogenesis of schizophrenia [9, lo] although the 
findings are controversial [Il. 121. DMT is also 
abused as a hallucinogen 113, 141. 
DMT is known to produce abnormal behavior in 
animals [15-211. Much of the speculation on the 
mode of action of DMT is centered on its interaction 
with 5-hydroxytryptamine (5-HT) [22,23]. Neverthe- 
less, the time course of the increase in brain 5-HT 
[23] seems in disagreement with the duration of its 
behavioral deficits [24]. Many explanations can be 
offered for this discrepancy. Nevertheless, the direct 
involvement of DMT in inducing behavioral deficits 
is the most parsimonious. DMT can readily be 
detected in the rat brain after systemic injections [25]. 
It is known to disappear very rapidly from biological 
tissues. However, to our knowledge no attempt has 
been made to determine its half-life in various tissues. 
The purpose of this study is to determine in rats 
the rate of disappearance of DMT and to determine 
whether DMT-induced behavioral deficits are corre- 
lated with its concentration in the brain. Sai-Hal&z 
[26] reported that the hallucinatory response to 
DMT in humans was diminished upon pretreatment 
with iproniazid. However, iproniazid prolonged and 
potentiated the toxic effects of DMT in animals using 
various behavioral endpoints [24].t Therefore, the 
effects of both iproniazid and the now more widely 
used monoamine oxidase (MAO) inhibitor tranylcy- 
* Supported in part by a grant from the State of Michi- 
gan for schizophrenia research. Part of this material was 
presented at the ASPET Meeting in Montreal. August 1974 
(PharmacologisT 16. 237. 1974). 
t M. Lutz and E. F. Domino. unpublished data. 
promine were studied to determine if such behavioral 
potentiation in rats was a direct result of an elevated 
tissue DMT level. 
METHODS 
Desigr~ qfeevpavimer~s. Male Holtzman rats. at least 
90 days old, weighing 400-450g. were used. Control 
animals received i.p. either 0.9?;, NaCl (l-2 ml,‘kg) 2 
and 16 hr, iproniazid (32 mg/kg) 16 hr. or tranylcypro- 
mine (IO mgjkg) 2 hr prior to guillotining. Experimen- 
tal rats received either 0.91; NaCl (2 ml/kg) 2 and 
16 hr, iproniazid (32 mg/2 ml/kg) 16 hr, or tranylcy- 
promine (10 mg/kg) 2 hr prior to the administration 
of DMT in doses of lPlO mgikg. In some experiments. 
14C-labeled DMT (side chain-[ 1-‘4C]. purchased 
from New England Nuclear) in a dose of 32mg/kg 
(sp. act. 0.94,Kimg) of compound was given. Each 
group consisted of five to ten animals. They were 
killed at different time intervals after DMT. After 
decapitation. the brain and liver were immediately 
removed and homogenized in 4 ml of ice-cold 1 N 
HCl. All data were compared with the controls run 
during the same experiment. Group comparison Stu- 
dent’s t-tests [27] were used to determine statistical 
significance. Groups of rats were trained to barpress 
on a fixed ratio of four barpresses to one milk reward 
(FR,) schedule [24]. Trained rats received either 3.2 
or 1Omgjkg of DMT i.p. The rats were sacrificed as 
soon as they resumed normal barpressing behavior. 
DMT content in brain was then analyzed. 
DMT a.ssu~. Homogenates were centrifuged at 
9000 q to give cleaner supernatants, which were separ- 
ated from precipitates and collected. The precipitates 
were each washed twice with 1.5 ml of 0.1 N HCl, 
shaken by a Vortex mixer, centrifuged. and the super- 
natants collected. All the acidic supernatants were 
then combined and used for subsequent assay. The 
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separation of supernatants is essential to gi\,c 2 clean 
extraction with organic ~l\cnt. To ~parate DMT 
from other mctabolites. the combined acidic supcrna- 
tants wcrc made basic with 2 ml of IO N NuOH and 
cstractcd with 30 ml of a mixture of ethyl acetate and 
tolucnc (1 : I by volume). An aliquot of 25 ml of the 
organic solvent was removed and shaken with ? ml 
of 0. I N HCI. DMT was determined fluoromctricallq 
(285 nm.350 nm. uncorrected) by the method of 
(‘ohen and Vogel [25] in the Farrand spcctrofluor- 
ometer. after the adjustment of the pH to X 9 with 
0.1 M sodium borate buffer. 
In those crpcrimcnts in which [‘5C’]DMT was 
given. the rats were sacrificed by decapitation IO min 
later. C!nchangcd [“C‘]DMT was cxtructcd according 
to the procedure described for the Ruorometric dctcr- 
mination. To count total Iradioactivit\i of unchanged 
[“CJDMT, an aliquot of 1.5ml of 0.1 N HCI was 
basificd with 100 ktl of IO N NaOH and extracted with 
3 ml of the mixture of ethyl acetate and tolucne. An 
aliquot of 2 ml of the organic phase was mixed with 
IO ml Aquafluor and counrcd in a liquid scintillation 
counter. The result obtained from this method was 
compared with that obtained from the fluorometric 
method. 
Qualitative prescncc of DMT in tissue extracts was 
demonstrated by thin-layer chromatography (t.1.c.) 
and radioscanning. The ethyl acetate and tolucnc 
phase of tissue extracts from rats receiving 
[“C]DMT was cvaporatcd to dryness under ;I 
nitrogen stream. The residue was redissol\,cd in 100 /(I 
ethyl acctatc. Aliquots of known radioactivity Mcrc 
spotted on a Silica gel GF plate (Analtech. Inc.. New 
ark. Del.) and dc\clopcd in the following sol\cnt s\s- 
tcms: (I ) methanolPconc. ammonium hydrox/dc 
(X)0:45); the R, of tryptaminc (T) wa 0.32. of 
.Y-meth\iltryptamine (NMT) 0. IX. and of DMT 0.42: 
(2) isopropanol IO”,, ammonium hydroxide water 
(200: IO:X); the K, value of T was 0.1 5. of NMT 0.05 
and of DMT 0.33: and (3) methanol tctrahydl-ofuran 
formic acid (50:50: I ); the R, value of T was 0.5. of 
NMT 0.32 and of DMT 0.25. Radioscanning of brain 
and liver extracts showed only one $pot with detect- 
able radioactivity and with an K, wluc of that of 
known DMT. T.1.c. plates were then scored and each 
segment was removed. Radionctivit? in each segment 
was counted in ;t liquid scintillatmn counter. The 
majority (97 9X per cent) of radioactivity, appcarcd 
in the scgmcnt with an R, of that of DMT in contrast 
to the radioactivity dctccted for that of T and NMT. 
(‘/I~wI~u// ccpir,‘irfior~ of rr.>~pro,~i,~c~ c~tl N-W/~\+ 
~I.I,/I~GI!I~~I~~ ,/ WII DA21 7‘. Samples containing indole- 
alkylamines (T. NMT or DMT. radioactive material 
if a\,ailablc) in 30 in1 of ethyl acetate and tolucnc wcrc 
cooled. and 0.5 ml trifluoroacctic anh) dridc (TFAA) 
was added. The mixtures were then set in an ice bath 
for 0.5 hr. Excess TFAA was then dcstrobed with 7 ml 
of ice-cold H30. basified with 3 ml of ION NaOH. 
iortcxccl. and centrifuged. Control samples which did 
not rccci\.e TFL\A were washed with IOtnl of ;i prc- 
mixed combination of ice-cold HI0 10 N NaOH 
trifluoroacctic anhydridc (7 ml : 3 ml :O.S ml). An ali- 
quot of 25 ml of the ethyl acetate and tolucnc phase 
was then transferred to another tube. cxtractcd with 
3 trill of 0. I N HC1. vortexed. and ccntrifugcd. An ali- 
quot of 7ml of 0.1 N HCI extract was ncutralizcd 
lvith I ml of ION NaOH with cooling. The h;tsic 
solution was then cxtractcd with 3 ml of a mixture 
of ethyl acctatc and tolucnc. To count total radioacti- 
vit). 2 ml of the organic phase was mixed with IO ml 
Ayuatluor and \V;IS counted in 21 liquid scintillation 
counter. In the cast‘ of NMT. where radioacti\c 
material was not available. the rccovcr\ and yield 01 
its reaction with TFAA \\crc dctcrmined h! ;I tluoro- 
metric method: an aliquot of I ml of 0.1 N HC‘I \\;I\; 
mixed with I ml of 0.1 M sodium borate huffc~- and 
fuorcscencc was rcud at an excitation uavclcnfth of 
2X5 nm and an emission v,a\clcnpth of 350 nm (un- 
corrected). 
Crrlc ~,lr~tio~\. The biological half-lift of DMT LV;IS 
dctcrmined according tc> the ecluation ,’ = (,(” 1’. 
\\hcrc J‘ is the original datum of DMT concentration 
in ,ffgg of tissue: .Y is time in min from i.p. injection 
of DMT to sacrifice; and (I rcprcsents the COIICCII- 
tration at zero time. Half-lift (r:?) was computed b! 
the equation (r:?) = -/I In 2 and estimated uccol-ding 
to the nonlincnr regression analysis of Gauss r2x]. 
E\poncntials wcrc fitted dircctl) by solving the “nor- 
mal equations of curve fitting” with reciprocals of the 
ohscrkcd variance cstimatcs as weights. The pm 
amctors (initial concentration and half-life) wcrc 
adlusted iterativcl\ until both were stable to 0.01 lw 
cent. C‘ontidcncc kits v,e~-c based on ;i small crroj 
anal! sis using the product-varlancc matri\. After i.p. 
iri,jection of DMT. its half-life was calculated from 
dat:t mcasurcd after pcsk tissue DMT lcvcls were 
I-cached. for absorption ix prcsumabl! complctc at 
that time. 
As described in Methods. a mixture of ethyl acctatc 
and tolucnc was LUX~ for the extraction of DMT from 
a basic tissue extract to ensure consistent and better 
recovery (X0-90 per cent). Eutrnction with toluenc 
alone, especially in the prcscnce of tissue. gave sari- 
able results of rccovcr!. The sensitivity of the assay 
is about 0.05 jcg.‘ml of sample. which is in agreement 
with Cohen and Vogel [Z-5]. 
Fluorescence of extracts from 0.9”,, NaU-pre- 
treated animals was negligihlc. Extracts of tissue from 
iproniazid-pretreated control animals gave s0111c 
Huoresccncc. This fluorescence could possibly come 
from endogenous T requiting from the prctrcatment 
of iproniazid rather than DMT. However. ~vhen it 
was calculated 21s if it were DMT. then the mean i 
S L E. Huoresccncc intensit) was CqLMI to 
0.50 & 0. IS /~g;g of bran and I. 16 & 0.13 pg;g of live1 
DMT. Tran~lcypromine-prctrc~~tcd control rats also 
gave some fluorescence. The mean i S. E. Iluores- 
ccncc intensity was cq~~:rl to 0.14 f 0.1 I /~g ‘g of brain 
and 0.45 5 0.07 /~g;g of liver DMT. 
Tahlc I lists DMT concentrations in rat tissues 
(control ~slues subtracted) 10 min after adminis- 
tration of the drug (3.1 mg/kg) as determined b) 
various methods. No signilicant diffcrcncc in DMT 
levels COLII~ be detcctcd bctwccn the two groups 01 
five to six rats. 
Thin-layer chromatography of the concentrated 
ethyl acetate and tolucnc phase of tissue extracts indi- 
catcd the prcscnce of DMT with an R, value of 0.41 
(McOH and NH&OH). 0.19 (isopropanol. IO”,, 
MAO inhlhitors and DMT in rat brain and liber I53 
Table I. C’omparison of DMT concentrations (~lg;g) in rat 
tissues (3.2 mg/kg at IO min) 
Fluoromctric Radioisotopic 
method method* P 
Bram 
Liver 
I .hO * 0. I I l.jS * 0.18 > 0.82 
1.56 + 0.2s 1.54 * 0.32 > 0.96 
* Each rat received 3 @kg. 1.p. The mean f S. E. of 
five to six rats is given for each method of assay. 
NH,OH and H20) and 0.25 (MeOH. tetrahydrofuran 
and formic acid). which wcrc in agreement with that 
of pure DMT. Radioscanning indicated one spot with 
detectahle radioactivity with the R, value of DMT. 
Figure 1 is a fow diagram of the separation of 
T and NMT from DMT by reaction with TFAA. Rc- 
covery results arc shown in Table 2. TFAA treatment 
removed 98 100 per cent of the T and NMT. 
The ethyl acctatc and toluene phase of the tissue 
extracts containing radioactive DMT or possibly 
NMT and T was equally divided into several por- 
tions. Half of the samples wcrc treated with TFAA 
and their recoveries of total radioactivity were com- 
pared with those samples which were not treated with 
TFAA. The data are given in Table 2. 
Figure 2 illustrates the concentration of DMT in 
rat brain and liver as a function of time after its i.p. 
administration. The peak concentration of DMT was 
reached around IOmin after injection in the 0.9”,, 
N&l-pretreated animals. After a dose of I mg/kg of 
DMT. it was possible to detect some DMT in 
brain (0.24 k 0.07 /[g/g) and liver (0.42 f 0.13 /‘gig) 3 
min after administration. The mean *SE. half-life 
of DMT in rat liver was estimated to be 5.9 k I.1 min 
Table 2. Per cent recovery of indolealkylamines after lhelr 
reaction with trifluoroacetic anhydride 
Reaction with TFAA 
Samples (0 ml TFAA) (0.5 ml TFAA) P 
DMT* 94.5 + 1.4(X)t s7 I * 1.7 (8) < 0.05 
NMT: 92.5 f X1(4) 0.0 (66 <O.OOl 
T 79.5 f 3.2 (5) 2.7 * 0.6 (5) <O.OOl 
Brain 94.1 + 1.2’ (6) 8X.3 i X4(6) NS 
cxtractsi 99.6 k 1.3’ (6) 106.4 f 4.1’ (6) NS 
Liver 99.’ * 1.p (6) x7.4 + 2.2 (7) NS 
extracts1 105.0 i 1.1’ (6) 103.7 5 2.6’ (7) NS _ 
* The purity of DMT. as determIned by t.1.c. and qua,l- 
tified by liquid scintillation counting. was 99 per cent. 
t Number of dctcrminations is in parentheses. Mean per 
cent k S. E. is given. 
$ Recolcry of NMT was determined h) Iluoromctric 
method. since its radioactive starting material was not 
available. 
? Fluorcsccncc readings were negligible. This Indicated 
that the removal of NMT was nearly complete. 
11 Tissue extracts wcrc obtained from rats given IO mg:kg 
of DMT (sp. act. 0.81 LKCrng), sacriticcd IO min after 
administration. 
’ Results were corrected lor rccoverics. Reaction of tis- 
slle extracts with or without TFAA did nol change the 
rcco\cry significantly. 
after a dose of 3.2 mg/kg and 7.4 + 0.7 min after a 
dose of IO mg!kg. There was a slight difference in the 
half-life of DMT at these two given doses. hut this 
was not statistically significant (P > 0.05. Fig. 2). Sur- 
prisingly different half-lives of DMT in the brain were 
noted after. different doses. The mean _C S. F_ half-lift 
Sample (containing NMT. T. DMT as free base) 
4 Dissolve in ethyl acetate and toluene mixture 
+ Add 0.5 ml TFAA 
+ Set for 4 hr in ice bath 
1 
Wash with ice H,O 
Neutralize with IO N NaOH 
Vortex. centrifuge 
I ml acid _ 
mixed with I ml of 
0.1 M sodium borate 
buffer. 
read fluorescence 
Organic layer (indolealkylamincs) 
1 







(containing amide of T and NMT) 
4 
Count 
Extract with ethyl acetate 
and tolucnc 
Fig. 1. Flow chart dlustrating the scpnratlon of T. NMT and DMT with TFAA 
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FIN. 2. Half-life of DMT 111 ~-at brain and liver. Each point represents the mean DMT concentration ot 
five to ten animals. Each group of animal\ wan aacrificcd by guillotine at various tlmc< after DMT 
lnjcction i.p. as illustrated. hotc that the hall’-life of DMT doffers in the bran when given in doses 
of 3.2 1s IO mg,‘kp i.p. On the other hand. the half-life of DMT m the liver IS the same irrespective 
of DMT in rat brain MX estimated to be 
6.5 + 0.7 min then pivcn in a dose of 3.2 rng/kg and 
12.5 + 0.Y min when given in a dose of IO mg;kg (Fig. 
2). The difference is hi&l? statisticall> significant 
(P < 0.001). If the rats were pretreated wtth 32 mg;kg 
of iproniazid i.p.. the mean & S. F. half-lift of DMT 
was estimated to be 30.6 2 I .7 min in brain and 
27.6 + 0.7 min in li\er (Fig. .3). The half--life of DMT 
in iproniu/id-prrtre~it~d animals was greatly increased 
for both brain and livci- from that of 0.9”,, NuCl-pre- 
treated animals (P < 0.001 ). The half-lift of DMT 
( 10 m,@kp) in tranylcyprominc-pretreated animals 
was 38.5 i_ 2.5 min in brain and 39.7 f 2.7 min in 
liber (Fig. 3). Tranylcypromine also greatly in- 
creased the half-life of DMT in both brain and liver 
( P < 0.001 1. 
C~~,.,.&ctio~~ hct,\~c,c~~ fi\a~/c ,!I!\1 T /c,r.c,l rrrld FR4 hco- 
pws,~im~ /w/ur~~ior ;,I dc Hdtxwr IYI~.Y. It has been 
prcviouslq observed by Kovactc and Domino 1741 
that rats trained to barpress for milk reward on an 
FRS schedule ceased to press for ;I mean period ol 
23 min aftcr 3.7 mg.kg of DMT. 46 min after IO mg.;kg 
of DMT, and I90 min in rats prctrcxted with ipronia- 
zid (31 mg’kg) Lund then given IO mg. kg of DMT I6 hr 
later. Little or no behavioral disruption could be 
observed after I mg kg of DMT. As is evident in Fig. 
2. the actual brain DMT level is about 0.41 /cg/g 
13 min after 3.1 mg:kg of DMT. The brain DMT level 
is about O.Y5 /~g p 36 min after 10 m&kg of DMT. 
Thcreforc. the minimal brain DMT level for supprcs- 
sion of barpressing behavior is hctween 0.31 and 
0.95 /Ip:p. 
To verify the estimated threshold DMT level foi 
disruption of barpressing behavior. groups of trained 
rats wcrc given either 3.2 or IOmg’kg of DMT i.p. 
The rats were sacrificed by decapitation as soon as 
they resumed normal barpressing behavior. The mean 
i_ S. E. in their brains was analyxd and found to 
he 0.48 i 0.09 &g of tissue after a dose of 3.3 rnz; kg 
and 0.90 t_ 0.13 pgg alien a dose of IO mg; kg of 
DMT. These data arc in agreement with the le\,els 
estimated through the time courses of clearnncc of 
brain DMT (Fig. 2). A slight but signiticant difTcrencc 
on the threshold levels for the disruption of bnrpress- 
ing behavior was noted upon the administration of 
different doses (3.2 and IO mg:kg) of DMT (P < 0.O.J). 
The reason for this discrepancy is unknown. 
Figure 4 illustrates the correlation hctueen the 
mean time required to reach minimal DMT conct’n- 
tration in tissues (0.34 ~cg;g of brain and 0.41 blg;g of 
liver) and the mean duration of suppression of FR1 
barpressing behavior. The values used arc the DMT 
concentrations in bruin and livct- after I mg kg of 
DMT i.p. There is a linear relationship hctween the 
mean time required to reach the minimal DMT con- 
centrations m tissues and the mean duration of SLIP- 
pression of FR4 barpressing behavior with a corrcla 
tion coefficient of 0.99 for brain (P c 0.02) and I .OO 
for liver (P < 0.001 ), Brain and liver DMT leveli; wc~c 
hi&ly correlated (I’ = 0.97. Fig. 5). 
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Fig. 3. Effects of iproniarid and tranylcypromine on the half-life of DMT in rat brain and liver. Note 
the difference in time scales between iproniazid and tranylcypromine pretreatment. After both MAO 
inhibitors. the half-lives of DMT in brain and liver are now similar. However. the half-lives of DMT 
for the tranylcypromine-pretreated animals are significantly longer than those of animals given iproniazid 
(P < 0.05). Iproniazid was given I6 hr and tranylcypromine 2 hr before DMT (10 mg/kg). 
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Fig. 4. Correlation between mean time required to reach minimal DMT concentratiorls in rat brain and 
liver and the duration of suppression of FR, barpresstng behavior. In view of the fact that I.0 mgikg i.p. 
of DMT produced little or no behavioral deficits and achieved a concentration of 0.24 jig/g of brain 
and 0.41 frgig of liver 3 min after injection, these concent~tions were chosen for these tissues. The time 
for DMT at the different doses to reach fhese levels was obtained from the half-life data described in 
Fig. 2. These times were correlated tvlth the duration of suppression of FR, barpressing behavior 
at the different doses from the data of Kovacic and Domino [24]. 
y=O 62x +060 
The slight modification of the cstroct~on prowdurc 
of Cohen and Vogel 1751 enabled us to analyle DMT 
in tissues for a longer period than that previously 
reported. The extraction procedure is standard ~OI- Ihc 
recovery of !\‘.R’-di-. -nwno- or -ilnsubstitutcd-i-indo- 
lealkylamines such 21s T. NMT and DMT. Thercforc. 
this assa! is not specific for DMT alone. which is 
in agreement with Gross and Franzcn [29] but dis- 
agrees with Cohen and Vogel [Xl. Within the sensi- 
tivitp limits of this assay procrdurc. there was ncglig- 
ihtc eintcrfcrence fl-om cndogenous indolealk!lamines. 
.\‘-demcthylation of DMT has bwn proposed ~OI- its 
biological disposition [IX)]. To check whcthcr this 
assa) procedure could be utili[cd for the assa\i of in- 
.jcctcd DMT. tissue extracts were trcatcd with trilluor- 
o,lcetic anh)dride. Lvhich con\crted primary and ‘ 
sccondx! nmincs to their corresponding amidcs. 
The) could thus hc separated from DMT by cstract- 
inp DMT into an acid. The reco\crics of tissue 
extracts treated with or without TFAA wcrc not st;i- 
tisticallq significant from ~ch other. Therefore no 
attempt was made to separate T and NMT. Hence 
this assay proczdurc was adapted for the purposes 
of this stud). 
A significant ditTercncc in the half-life of DMT in 
rat brain was noted after administration of two ditfcr- 
ent doses. This suggests that different modes of clcar- 
;IIKX of DMT exist in the brain. Larget- doses 
(IO mg kg) of DMT rcsultcd in a slo\lzr rate of clcar- 
ancc. This probably Iresultcd from monoamine axi- 
dasc inhibition h\ the high doses of DMT. for it ih 
known that tertiary amines can hc weak MAO inhihi- 
tars and that DMT inhibits this enqmc [31].* Thtxe 
was no significant ditfercncc in the ha1Flifc of DMT 
in the liver after 3.2 or IO mg:\g, (P > 0.05). Although 
liver MAO might also be inhthitrd t?! DMT i/l Cro. 
this is not the only enryne in the hvcr w111ch can 
biotransform DMT. On the other hand, it is generaIl) 
a~sumcd that amines in brain arc hiotransformed 
MAO inhibitors and DMT in rat brain and liver I527 
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